U.S. markets close in 1 hour 10 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
61.08-0.04 (-0.07%)
As of 2:49PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close61.12
Open61.07
Bid61.17 x 800
Ask61.18 x 800
Day's Range60.96 - 61.87
52 Week Range57.04 - 85.97
Volume4,186,263
Avg. Volume9,552,931
Market Cap76.563B
Beta (5Y Monthly)0.55
PE Ratio (TTM)60.66
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.72 (4.45%)
Ex-Dividend DateDec 14, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
19% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • 3 Pharma Stocks With Dividends Above 4% to Buy Now
    Motley Fool

    3 Pharma Stocks With Dividends Above 4% to Buy Now

    Investors looking for dividend-paying stocks that offer juicy yields right now can find what they're looking for in the biopharmaceutical industry. All three of these big pharmaceutical companies have well-funded dividend programs that offer juicy yields above 4% right now. Since spinning off from Abbott in 2013, AbbVie has raised its dividend payout a whopping 225% with help from its top-selling rheumatoid arthritis treatment, Humira.

  • Investopedia

    2 Biotech Funds Poised for a Healthy Breakout

    Biotech stocks are likely to remain in focus through year end amid news surrounding COVID-19 vaccines and treatments.

  • Is Gilead Sciences a Great Dividend Stock?
    Motley Fool

    Is Gilead Sciences a Great Dividend Stock?

    When you think about dividend stocks, biotechs probably don't immediately come to mind. Gilead Sciences' (NASDAQ: GILD) dividend program especially stands out. The company arguably offers the best dividend of any biotech.